Home/Natco Pharma/M. Adinarayana
MA

M. Adinarayana

Chief Financial Officer

Natco Pharma

Natco Pharma Pipeline

DrugIndicationPhase
Generic Lenalidomide (Revlimid)Multiple Myeloma, Myelodysplastic SyndromesLaunched
Generic Oseltamivir (Tamiflu)InfluenzaLaunched
Generic Glatiramer Acetate (Copaxone)Multiple SclerosisLaunched
Generic Imatinib (Gleevec)Chronic Myeloid Leukemia, Gastrointestinal Stromal TumorLaunched
Portfolio of Oncology Injectables (e.g., Pemetrexed, Bortezomib)Various CancersANDA Filed / Development
Hepatitis C Antiviral CombinationsHepatitis C Virus InfectionLaunched
Generic Oxycodone ER (Oxycontin)Pain ManagementLaunched